Generation and characterization of recombinant unmodified and phosphorylatable murine IFN-α1 in the methylotropic yeast Pichia pastoris

Journal of Interferon and Cytokine Research

Volumn 23, Issue 7, 2003, Pages 351-358

  Trajanovska, S ^a   Owczarek, Catherine M ^a   Stanton, P G ^b   Hertzog, P J ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 1P INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA1 INTERFERON; CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERFERON ANTIBODY; PHOSPHORUS 32; PROTEIN IFNAR1; PROTEIN IFNAR2; RECOMBINANT INTERFERON; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CELL TYPE; DOSE RESPONSE; ELECTROPHORESIS; ELUTION; ENZYME ANALYSIS; GENETIC TRANSFECTION; ISOTOPE LABELING; MOUSE; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; RECEPTOR BINDING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STATISTICAL SIGNIFICANCE; YEAST;

ANIMALS; BINDING SITES; CELL DIVISION; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COS CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSYLATION; INTERFERON-ALPHA; MICE; PHOSPHORYLATION; PICHIA; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERFERON; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFECTION;

ANIMALIA; MURINAE; PICHIA; PICHIA PASTORIS;

EID: 0038036420     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999003322226005     Document Type: Article

References (43)

1. PESTKA, S., LANGER, J.A., ZOON, K.C., and SAMUEL, C.E. (1987). Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
2. STARK, G.R., KERR, I.M., WILLIAMS, B.R.G., SILVERMAN, R.H., and SCHREIBER, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
3. FLORES, I., MARIANO, T.M., and PESTKA, S. (1991). Human interferon omega binds to the alpha/beta receptor. J. Biol. Chem. 266, 19875-19877.
4. LAFLEUR, D.W., NARDELLI, B., TSAREVA, T., MATHER, D., FENG, P., SEMENUK, M., TAYLOR, K., BUERGIN, M., CHINCHILLA, D., ROSHKE, V., CHEN, G., RUBEN, S.M., PITHA, P.M., COLEMAN, T.A., and MOORE, P.A. (2001). Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J. Biol. Chem. 276, 39765-39771.
5. WEISSMANN, C. and WEBER, H. (1986). The interferon genes. Prog. Nucleic Acid Res. Mol. Biol. 33, 251-300.
6. ORITANI, K., MEDINA, K.L., TOMIYAMA, Y., ISHIKAWA, J., OKAJIMA, Y., OGAWA, M., YOKOTA, T., AOYAMA, K., TAKAHASHI, I., KINCADE, P.W., and MATSUZAWA, Y. (2000). Limitin: an interferon-like cytokine that preferentially influences. Nat. Med. 6, 659-666.
7. DE MAEYER, E., and DE MAEYER-GUIGNARD, J. (1992). Interferon-gamma. Curr. Opin. Immunol. 4, 321-326.
8. UZE, G., LUTFALLA, G., and GRESSER, I. (1990). Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234.
9. UZE, G., LUTFALLA, G., BANDU, M.T., PROUDHON, D., and MOGENSEN, K.E. (1992). Behavior of a cloned murine interferon alpha/beta receptor expressed in homospecific or heterospecific background. Proc. Natl. Acad. Sci. USA 89, 4774-4778.
10. COLAMONICI, O.R., PORTERFIELD, B., DOMANSKI, P., CONSTANTINESCU, S., and PFEFFER, L.M. (1994). Complementation of the interferon alpha response in resistant cells by expression of the cloned subunit of the interferon alpha receptor. A central role of this subunit in interferon alpha signaling. J. Biol. Chem. 269, 9598-9602.
11. SOH, J., MARIANO, T.M., LIM, J.K., IZOTOVA, L., MIROCHNITCHENKO, O., SCHWARTZ, B., LANGER, J.A., and PESTKA, S. (1994). Expression of a functional human type I interferon receptor in hamster cells: application of functional yeast artificial chromosome (YAC) screening. J. Biol. Chem. 269, 18102-18110.
12. NOVICK, D., COHEN, B., and RUBINSTEIN, M. (1994). The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77, 391-400.
13. OWCZAREK, C.M., HWANG, S.Y., HOLLAND, K.A., GULLUYAN, L.M., TAVARIA, M., WEAVER, B., REICH, N.C., KOLA, I., and HERTZOG, P.J. (1997). Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR-2. J. Biol. Chem. 272, 23865-23870.
14. KIM, S.H., COHEN, B., NOVICK, D., and RUBINSTEIN, M. (1997). Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2. Gene 196, 279-286.
15. COHEN, B., NOVICK, D., BARAK, S., and RUBINSTEIN, M. (1995). Ligand-induced association of the type I interferon receptor components. Mol. Cell. Biol. 15, 4208-4214.
16. PIEHLER, J., and SCHREIBER, G. (1999). Biophysical analysis of the interaction of human IFNAR2 expressed in E. coli with IFN alpha 2. J. Mol. Biol. 289, 57-67.
17. HWANG, S.Y., HERTZOG, P.J., HOLLAND, K.A., SUMARSONO, S.H., TYMMS, M.J., HAMILTON, J.A., WHITTY, G., BERTONCELLO, I., and KOLA, I. (1995). A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. USA 92, 11284-11288.
18. LI, B.L., LANGER, J.A., SCHWARTZ, B., and PESTKA, S. (1989). Creation of phosphorylation sites in proteins: construction of a phosphorylatable human interferon alpha. Proc. Natl. Acad. Sci. USA 86, 558-562.
19. 32P-labeled murine immune interferon and its binding to the mouse immune interferon receptor. J. Biol. Chem. 261, 9801-9804.
20. OWCZAREK, C.M., ZHANG, Y., LAYTON, M.J., METCALF, D., ROBERTS, B., and NICOLA, N.A. (1997). The unusual species cross-reactivity of the leukemia inhibitory factor receptor alpha-chain is determined primarily by the immunoglobulin-like domain. J. Biol. Chem. 272, 23976-23985.
21. ZHANG, J.G., OWCZAREK, C.M., WARD, L.D., HOWLETT, G.J., FABRI, L.J., ROBERTS, B.A., and NICOLA, N.A. (1997). Evidence for the formation of a heterotrimeric complex of leukaemia inhibitory factor with its receptor subunits in solution. Biochem. J. 325, 693-700.
22. CREGG, J.M., CEREGHINO, J.L., SHI, J., and HIGGINS, D.R. (2000). Recombinant protein expression in Pichia pastoris. Mol. Biotechnol. 16, 23-52.
23. FAMILLETTI, P.C., RUBINSTEIN, S., and PESTKA, S. (1981). A convenient and rapid cytopathic effect inhibition assay for interferon. Methods Enzymol. 78, 387-394.
24. MIZUSHIMA, S., and NAGATA, S. (1990). pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18, 5322.
25. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
26. HARDY, M.P., OWCZAREK, C.M., TRAJANOVSKA, S., LIU, X., KOLA, I., and HERTZOG, P.J. (2001). The soluble murine type I interferon receptor IFNAR-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties. Blood 97, 473-482.
27. ZHAO, X.X., LI, B.L., LANGER, J.A., VAN RIPER, G., and PESTKA, S. (1989). Construction and phosphorylation of a fusion protein Hu-IFN-alpha A/gamma. Anal. Biochem 178, 342-347.
28. HERTZOG, P.J., HWANG, S.Y., HOLLAND, K.A., TYMMS, M.J., IANNELLO, R., and KOLA, I. (1994). A gene on human chromosome 21 located in the region 21q22.2 to 21q22.3 encodes a factor necessary for signal transduction and antiviral response to type I interferons. J. Biol. Chem. 269, 14088-14093.
29. HEUKESHOVEN, J., and DERNICK, R. (1988). Improved silver stain procedure for fast staining in PhastSystem development unit. I. Staining of sodium dodocyl sulfate gels. Electrophoresis 9, 28-32.
30. COLAMONICI, O.R., and DOMANSKI, P. (1993). Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. J. Biol. Chem. 268, 10895-10899.
31. PLATANIAS, L.C., PFEFFER, L.M., CRUCIANI, R., and COLAMONICI, O.R. (1993). Characterization of the alpha subunit of the IFN-alpha receptor. Evidence of N- and O-linked glycosylation and association with other surface proteins. J. Immunol. 150, 3382-3388.
32. CONSTANTINESCU, S.N., CROZE, E., MURTI, A., WANG, C., BASU, L., HOLLANDER, D., RUSSELL-HARDE, D., BETTS, M., GARCIA-MARTINEZ, V., and MULLERSMAN, J.E. (1995). Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex. Proc. Natl. Acad. Sci. USA 92, 10487-10491.
33. LUTFALLA, G., HOLLAND, S.J., CINATO, E., MONNERON, D., REBOUL, J., ROGERS, N.C., SMITH, J.M., STARK, G.R., GARDINER, K., and MOGENSEN, K.E. (1995). Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 14, 5100-5108.
34. CUTRONE, E.C., and LANGER, J.A. (1997). Contributions of cloned type I interferon receptor subunits to differential ligand binding. FEBS Lett. 404, 197-202.
35. CRESPO, A., FILLA, M.B., RUSSELL, S.W., and MURPHY, W.J. (2000). Indirect induction of suppressor of cytokine signalling-1 in macrophages stimulated with bacterial lipopolysaccharide: partial role of autocrine/paracrine interferon-alpha/beta. Biochem. J. 349, 99-104.
36. MURPHY, K.P., Jr., GAGNE, P., PAZMANY, C., and MOODY, M.D. (1998). Expression of human interleukin-17 in Pichia pastoris: purification and characterization. Protein Exp. Purif. 12, 208-214.
37. CHATANI, E., TANIMIZU, N., UENO, H., and HAYASHI, R. (2000). Expression of soluble bovine pancreatic ribonuclease A in Pichia pastoris and its purification and characterization. Biosci. Biotechnol. Biochem. 64, 2437-2444.
38. NYMAN, T.A., KALKKINEN, N., TOLO, H., and HELIN, J. (1998). Structural characterisation of N-linked and O-linked oligosaccharides derived from interferon-alpha2b and interferon-alpha14c produced by Sendai virus-induced human peripheral blood leukocytes. Eur. J. Biochem 253, 485-493.
39. KONTSEK, P. (1994). Human type I interferons: structure and function. Acta Virol. 38, 345-360.
40. HAGENSON, M.J., HOLDEN, K.A., PARKER, K.A., WOOD, P.J., CRUZE, J.A., FUKE, M., HOPKINS, T.R., and STROMAN, D.W. (1989). Expression of streptokinase in Pichia pastoris yeast. Enzyme Microbiol. Technol. 11, 650-656.
41. CLARE, J.J., RAYMENT, F.B., BALLANTINE, S.P., SREEKRISHNA, K., and ROMANOS, M.A. (1991). High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene. Biotechnology 9, 455-460.
42. BOYER, S.J., COLLEY, S.M., LAI, C.M., SWAMINATHAN, N., SMITH, W.A., and BEILHARZ, M.W. (1992). Rapid high level production and purification of recombinant murine and human interferons alpha from Escherichia coli. J. Biol. Regul. Homeost. Agents 6, 99-102.
43. DRON, M., TOVEY, M.G., MAURY, C., EID, P., MEYER, F., and GRESSER, I. (1989). Production and in vivo biologic actions of recombinant mouse interferon alpha 2. J. Biol. Regul. Homeost. Agents 3, 13-19.